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Introduction 
The use of calcium phosphate (CaP) based 
carriers in bone engineering is a promising 
approach for a local in-vivo enrichment of 
calcium (Ca2+) and phosphate (Pi) to trigger 
progenitor/stem cells towards bone formation. 
The aim of this study was to mimic the Ca2+ and 
Pi ion-enriched environment in-vitro to assess 
the effect of these ions on the proliferation and 
osteogenic differentiation of human periosteum 
derived cells (hPDCs). 
 
Materials and Methods 
Culture medium containing 1% Ca2+ or Pi (0, 2, 
4, 6, 8 and 10 mM) in hepes buffered solutions 
were added to hPDCs cultures and incubated for 
1, 3, 7, 14, 21 and 28 days. Cell proliferation, 
cell cycle progression, alkaline phosphatase 
(ALP) activity, expression of osteogenic marker 
genes (osteocalcin (OCN), osteopontin (OPN), 
bone morphogenetic protein-2 (BMP-2) and 
Runx2) and mineralisation were evaluated. 
Statistical significance was established at α< 
0.05 by using unpaired student t-test (two-tailed) 
or one-way ANOVA analysis.  
 
Results 
The Ca2+ and Pi treatment caused a time- and 
dose-dependent phenotypic change and 
aggregation of hPDCs, without any cell death 
after 28 days of culture. 4 to 8 mM of Ca2+ and 
Pi enhanced cell growth significantly from day 3 
till 28 similar to mitogenic effect of osteogenic 
medium. This effect was supported by cell cycle 
analysis showing a dose- and time-dependent 
shift towards cells in synthesis (S) and mitotic 
(M) phases. However, a significant increase in 
ALP activity could not be detected with any 
treatment. With regard to gene expression, for 
certain conditions both Ca2+ and Pi significantly 
upregulated OCN and BMP-2 genes as early as 
from day 7. OPN and Runx2 were upregulated 
significantly by Pi and to a lesser extent by Ca2+. 
Alizarin red staining confirmed the presence of 
mineral deposits in Pi, but not in Ca2+ treated 
cultures after 21 days. Scanning electron 
microscopy revealed matrix vesicle-like 
structures (~400 nm) and cell-mineral nodules 
interactions in Pi-treated samples.  
 
Figure 1: In vitro osteocalcin gene expression of (a) 
Ca2+ and (b) Pi treated hPDCs over the 28 days of 
treatment. Mean + S.E.M. (n = 3). Unpaired student t-
test (two tailed):*p<0.05, **p<0.01, ***p<0.001. 
 
Discussion and Conclusions 
By mimicking the in-vivo CaP-enriched 
environment in-vitro, we show that Ca2+ and Pi 
induced cell proliferation by regulating cell cycle 
progression in a dose- and time-dependent 
manner. This is believed to be essential for 
achieving a critical cell mass that would initiate 
bone formation. Dissolved Ca2+ and Pi did not 
induce ALP production, but we observed a dose-
dependent upregulation of osteogenic genes 
expression, important for the regulation of 
extracellular matrix mineralisation. This study 
implies a potential method to differentiate stem 
cells towards the osteogenic lineage for effective 
bone engineering. 
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